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Introduction
Overweight and obesity are global diseases affecting at least 1 
in 3 adults and 1 in 5 children according to the Organization 
for Economic Co-operation and Development.1 The preva-
lence of overweight children is approximately 22.5% and 7.9% 
in Singapore and Thailand, respectively.2 In Malaysia, the 
National Health and Morbidity Survey reported an 11.9% 
incidence of obesity among children under 18 years old. The 
highest obesity rate was found in Perak (14.1%) and preva-
lence of obesity higher among boys compared to girls. 
Furthermore, rates of obesity were greater among urban chil-
dren (12.1%) compared to those from the rural area (11.2%). 
Among Malaysian ethnic groups, Chinese has the highest 
obesity (13.0%), followed by Indians (12.6%) and Malays 
(11.8%). Children are overweight for a variety of reasons, such 
as unhealthy eating patterns, lack of physical activity, genetic 
factors, or a combination of these factors.3 Childhood obesity 
facilitates alteration of the gut microbiome through various 
health factors such as insulin resistance and type 2 diabetes, 
hyperlipidemia, hypertension, renal and liver disease, as well as 
reproductive dysfunction. Modulation of the gut microbiota 
among obese humans showed that the gut microbiome of 
obese individuals had a decrease in the gram-positive bacterial 
phyla Firmicutes and Actinobacteria.4
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ABSTRACT: Childhood obesity is a serious public health problem worldwide. Perturbations in the gut microbiota composition have been asso-
ciated with the development of obesity in both children and adults. Probiotics, on the other hand, are proven to restore the composition of the 
gut microbiome which helps reduce the development of obesity. However, data on the effect of probiotics on gut microbiota and its associa-
tion with childhood obesity is limited. This study aims to determine the effect of probiotics supplement intervention on gut microbiota profiles 
in obese and normal-weight children. A total of 37 children, 17 normal weight, and 20 overweight school children from a government school in 
Selangor were selected to participate in this study. Participants were further divided into intervention and control groups. The intervention groups 
received daily probiotic drinks while the control groups continued eating their typical diet. Fecal samples were collected from the participants 
for DNA extraction. The hypervariable V3 and V4 regions of 16S rRNA gene were amplified and sequenced using the Illumina MiSeq platform. 
No significant differences in alpha diversity were observed between normal weight and obese children in terms of the Shannon Index for even-
ness or species richness. However, a higher intervention effect on alpha diversity was observed among normal-weight participants compared 
to obese. The participants’ microbiome was found to fluctuate throughout the study. Analysis of the taxa at species level showed an increase in 
Bacteroides ovatus among the normal weight cohort. Genus-level comparison revealed a rise in genus Lachnospira and Ruminococcus in the 
overweight participants after intervention, compared to the normal-weight participants. The probiotics intervention causes an alteration in gut 
microbiota composition in both normal and overweight children. Though the association could not be defined statistically, this study has provided 
an improved understanding of the intervention effect of probiotics on gut microbiome dysbiosis in an underrepresented population.
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The gut microbiome is the most diverse human microbi-
ome, consisting of thousands of bacterial species. The human 
gut microbiome is comprised largely of strict anaerobes and 
facultative anaerobes, which are generally discussed at 
the phylum level of taxonomic rank. To date, more than 
50 bacterial phyla expressing approximately 3.3 million 
prokaryotic genes have been identified. However, prior work 
has shown, the gut microbiome is largely dominated by 3 
phyla, Bacteroidetes (Porphyromonas, Prevotella), Firmicutes 
(Ruminococcus, Clostridium, and Eubacteria), and Actinobacteria 
(Bifidobacterium).5 This gut microbiota interact with one 
another as well as with the host, impacting the host’s physiol-
ogy and health. Among the significant roles played by the gut 
microbiota in humans are vitamin synthesis, digestion 
improvement, nutrient and mineral absorption, angiogenesis 
promotion, production of short-chain fatty acids (SCFAs), 
and nervous system function. The by-products of fermenta-
tion such as acetate, propionate, and butyrate are vital for the 
gastrointestinal tract (GIT), provide energy for epithelial cells, 
enhance the epithelial barrier integrity, and provide immu-
nomodulation and protection against pathogens.6 Recent 
studies have investigated the bacterial gene function and its 
potential role in human health and metabolism.7 The altera-
tion of the gut microbiota components or dysbiosis has also 
been shown to lead to various diseases such as inflammatory 
bowel disease, cardiovascular disease, and even cancer.8
Alteration of the gut microbiome is initiated by various fac-
tors including diet, medications, stress, obesity, environment 
and comorbid diseases such as heart disease or diabetes. 
Current evidence supports a link between obesity and compo-
sition of the gut microbiota. In contrast, probiotic administra-
tion containing the genus Lactobacillus has led to significant 
differences in microbial community composition, a reduced 
Firmicutes: Bacteroides ratio as well as an increased abundance 
of Verrucomicrobia.9
Probiotics have been proven to influence glucose and fat 
metabolism, reduce body weight, and improve insulin sensitiv-
ity. Hence, it has the potential of a dietary intervention to treat 
obesity.10 The effects of probiotics are mostly established for 
the Lactobacillus and Bifidobacterium strains in Western cul-
tures, but there is very limited information available from the 
Asia-Pacific region.11 Due to the diverse epidemiological 
health system and socio-economic conditions, there is a grow-
ing need to explore the association between gut microbiota and 
obesity in this geographical region. This pilot study was con-
ducted to identify the intervention effect of a probiotics drink 
on the alteration of gut microflora among normal and over-
weight school children from Selangor, Malaysia.
Methods
Study design
Study approval was obtained from the Ethics Committee for 
Research Involving Human Subjects Universiti Putra Malaysia 
( JKEUPM), Malaysia [FPSK_November (13) 03], Ministry of 
Education (MOE), Putrajaya [KP(BPPDP)603/5/JLD.16(154)] 
and Department of Education of Selangor, Shah Alam ( JPNS.
PPN 600-1/49 JLD.32(32)]. The study was a randomized and 
cross-over design with 2 phases. Each phase lasted 4 weeks with 
a 4-week wash-out period in between to prevent carry-over 
effects from the previous treatment. All the procedures were car-
ried out following the Helsinki Declaration of 1975, revised in 
2008. Consent was obtained from all the subjects who met the 
inclusion and exclusion criteria of the study.
Study population
This study included school children from a government school in 
Selangor. The subjects were recruited in 2 different groups, 
namely normal weight, and overweight. To meet inclusion crite-
ria for the study a participant had to be Malaysian, a registered 
student, and aged 7 to 10 years old. Z-scores for BMI-for-age of 
−2.0 SD to +1.0 SD were designated as normal weight and more 
than +2 SD was designated as overweight. Exclusion criteria 
included vaccination within 1 month of the study start, antibiotic 
treatments 2 weeks before sample collection, and subjects cur-
rently taking probiotics supplements. A total of thirty-seven (37) 
subjects comprised of seventeen normal weight and 20 over-
weight children were enrolled in the study, with thirty-five (35) 
completing the study. One normal weight participant and 1 over-
weight participant were unable to collect all samples and were 
thus excluded from analyses. Population characteristics and 
demographics of the remaining study participants are further 
detailed in Table 1. Phase groups were well-balanced between 
normal and overweight children, except unequal variance in 
weight between normal and overweight participant groups 
(F-test for variance, Group 1: P = 0.006, Group 2: P = 0.046).
Probiotics drink
The probiotic drinks were bottles of Lactobacillus fermented 
milk (LcS) containing glucose, fructose, maltitol, and skimmed 
milk powder. The components of each 80 ml bottle were energy, 
46 kcal; protein, 0.9 g; fats, 0 g; carbohydrates, 10.6 g; sugar, 
7.6 g; and dietary fiber, 0.2 g, and approximately 3.0 × 1010 
colony-forming units (CFU) of LcS.
Study protocol
Subjects were separated into 2 groups, normal weight, and 
overweight. They were further divided into intervention and 
control groups. During the first 4 weeks, the phase 1 interven-
tion group received LcS probiotic drinks for daily consumption 
while the control groups continued their typical diet. This was 
followed by 4 weeks of wash-out period. After, we conducted a 
cross-over, where subjects who were not provided the probiotic 
drinks in phase 1 were given LcS probiotic drinks and vice-
versa. The intervention period continued for another 4 weeks 
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and is referred to as phase 2. Throughout the intervention 
study, subjects were required to consume a common diet as 
other Malaysian children and continue their routine physical 
activities.12
Fecal sample collection and DNA extraction
Fecal samples were collected from the subjects at week 0, week 
5, week 10, and week 15. The flow of the study design indicat-
ing the study duration, probiotic consumption, and sample col-
lection can be seen in Figure 1. Approximately 1 g feces were 
collected from the subjects at each time point using a sterile 
fecal collection tube and stored at −80°C for further processing. 
Approximately 200 mg of the fecal samples were mixed with 
1 ml InhibitEX Buffer in a 2 ml microcentrifuge tube and vor-
texed thoroughly to homogenize the sample. DNA was 
extracted using QIAamp® Fast DNA Stool Mini kit per the 
manufacturer’s instructions.13 The DNA was eluted using 200 
uL elution buffer (0.1 mM EDTA, 10 mM Tris-HCl, 0.1% 
sodium azide, pH 8.0) and was stored at −20°C prior to 
sequencing. The concentration and purity of the extracted 
DNA were determined using Nanodrop 1000 v3.7.1 (Thermo 
Fisher Scientific, Massachusetts, U.S).
DNA amplif ication and sequencing
The V3-V4 region of 16S rRNA gene was amplified using for-
ward primer (5’–TCGTCGGCAGCGTCAGATGTGTA 
TAAGAGACAGCCTACGGGNGGCWGCAG–3’) and 
reverse primer (5’–GTCTCGTGGGCTCGGAGATGT 
G TATA A G A G A C A G G A C TA C H V G G G TAT C 
TAATCC–3’). These primers contain partial Illumina Nextera 
adapter. The pooled libraries were then quantified, denatured 
and sequenced on Illumina MiSeq platform.14,15
Sequence data analysis and OTU table construction
Raw FASTQ files were quality controlled using the pipeline 
SHI7.16 Nextera sequencing adapters were removed and all 
sequences trimmed until a threshold average quality score of 
>35 was achieved. Sequences not meeting these criteria were 
omitted. We performed Operational Taxonomic Unit (OTU) 
picking on the remaining samples with the exhaustive optimal 
alignment software BURST against the GreenGenes (version 
13_8) database clustered at 97% identity.17 In total, 88.8% of 
quality-controlled reads were assigned to an OTU for down-
stream analyses. The resulting OTU and taxonomy tables were 
then filtered using the statistical software R to remove single-
tons and OTUs of extremely low confidence (<0.01% average 
sample relative abundance). Before performing differential 
taxon abundance analyses, OTU and taxonomy tables were rar-
efied to a depth of 4018 reads and 4068 reads, respectively, as 
well as transformed using a centered log-ratio (CLR) trans-
form, thus eliminating the need for a reference value in the Ta
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4 Evolutionary Bioinformatics 
creation of normalized, per-sample relative abundance tables. 
Custom analyses in R were created for computing diversity 
measures, conducting statistical tests, and generating figures 
using the vegan, ape, phyloseq, and ggplot2 packages.18-21 In 
statistical tests, all associations producing an FDR-adjusted 
P-value < 0.05 were considered significant.
Results
Probiotic intervention effect on alpha diversity
Alpha diversity, within sample diversity, was quantified using 
the Shannon diversity index, incorporating both OTU richness 
and evenness. A higher Shannon index is indicative of greater 
species diversity within a sample. To specifically identify the 
probiotic intervention impact on alpha diversity, intervention 
impact was defined as the change in Shannon diversity index 
per individual during their intervention period, subtracting the 
prior-to-intervention sample Shannon index value from the 
post-intervention sample value. An unpaired t-test revealed no 
significant difference between weight statuses in terms of this 
intervention impact (Figure 2). However, a greater percentage 
of normal weight individuals exhibited a positive intervention 
effect (68.75%) compared to overweight individuals (57.89%), 
implying children in the normal weight category more com-
monly experienced greater alpha diversity following a probiot-
ics intervention.
Probiotic intervention effect on beta diversity
We evaluated differences between bacterial communities using 
weighted UniFrac distance, incorporating phylogenetic relat-
edness, of all present OTUs after rarefaction. We stratified beta 
diversity analyses by phase groups, where phase 1 received the 
probiotic intervention prior to the week 5 sample and phase 2 
conducted their intervention phase prior to week 15. Within 
each phase, we evaluated the impact of the week category, to 
Figure 1. Cross-over study design. in the first 4 weeks, the phase 1 intervention groups received LcS probiotic drinks for daily consumption while the 
control groups continued their typical diet. This was followed by 4 weeks of wash-out period. Later, there was a cross-over, where subjects who were not 
provided the probiotic drinks before were given LcS probiotic drinks and vice-versa. The intervention period continued for another 4 weeks and subjects 
participating in this later probiotics intervention are referred to as “phase 2.”
***iNTERVENTiON = Probiotic administration in the past 4 weeks lapse. 
Control = No probiotic administration from past 4 weeks.
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see if there was a temporal effect on microbial composition. 
Interestingly, we found a significant temporal effect in phase 1 
(Mann–Whitney U test, P < 0.05) but not phase 2. This is 
indicative of a shift induced by intervention and prolonged in 
the weeks following, as the significant impact of time is only 
seen in the group with the earlier intervention. In order to 
determine an explicit intervention impact, we further separated 
analyses into 2 sets of samples regardless of phase, before an 
intervention period and immediately after the intervention 
period. Without the baseline reference groups, significance of 
the intervention impact on microbial profile was lost. To visu-
alize these analyses, we conducted Principal Coordinates 
Analysis (PCoA) on each phase, illustrating the 95% confi-
dence interval of each set of samples with ellipses (Figure 3A).
To further investigate the impact of our probiotics interven-
tion as well as weight status, we conducted redundancy analysis 
(RDA) on the CLR -transformed OTU tables using the RDA 
function in the R vegan package. The RDA stratified by phase 
once again and constrained for weight and probiotics interven-
tion as well as other suspected confounding variables such as 
age, gender, and week of sample collection. After comparing 
these constraints to an unconstrained RDA, we were able to 
determine the adjusted R-squared and proportion of variance 
explained by each variable in the constrained RDA for phase 1 
(Table 2A) and phase 2 (Table 2B), respectively. Significance of 
each variable in determining RDA distance was evaluated using 
the env.fit function in the vegan package in R. Remaining con-
sistent with our findings with weighted UniFrac and PCoA, we 
found an intervention effect was only significant within the first 
phase (PERMANOVA, P-value < 0.05). Using the same subset 
of samples from looking for weighted UniFrac intervention 
Figure 2. The intervention effect on alpha diversity measured using 
Shannon diversity index plot for normal weight (orange) and overweight 
(blue) children. A higher Shannon index implies greater alpha diversity, 
both in terms of OTU richness and evenness. The median is represented 
by the line inside the box, while the lowest and the highest values within 
the 1.5 interquartile range (iQR) are represented by the whiskers. The 
individual sample values including outliers are shown as points over the 
boxes. An unpaired t-test showed no significant difference in intervention 
effect between weight status groups (P = 0.164).
Figure 3. Principal coordinates analysis (PCoA) using weighted UniFrac distances across all present OTUs within each phase and then combining 
phases but showing only the samples taken immediately before and after the probiotics intervention in each phase (A). Only phase 1 showed a significant 
relationship with weeks (PERMANOVA, P < 0.05). Using the same subsets of samples, a constrained RDA is shown below each PCoA plot, annotated 
with arrows to indicate the direction of significant variables in the RDA ordination space. Points in all figures represent samples, where more similar 
samples appear closer together.
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effects within both phases, we found significance in terms of 
constrained RDA variation (PERMANOVA, P = 0.01). This 
could be because the constraints in RDA restricted the variation 
explained on each axis to severely less than PCoA, as repre-
sented by the percentages of variance listed alongside each axis 
(Figure 3B). So, the intervention effects appear to have signifi-
cantly impacted only a small proportion of what we know as the 
microbial profile of our samples.
The probiotics intervention impact is further illustrated by 
looking at shifts within subjects. Stratifying by weight status, 
we plotted the samples before and after probiotics intervention 
per subject, connecting samples from the same subject by col-
oring them alike and drawing an arrow indicating before to 
after effect (Figure 4). The high variance across individuals 
regardless of phase and weight status implies probiotics inter-
vention effects may be strongly confounded with high subject-
to-subject variance and low sample size in this pilot study.
Relative abundance of the most prevalent bacteria 
at varying taxonomic ranks
Genus-level taxonomic profiling of normal and overweight 
subjects revealed varied changes in bacterial relative abundance 
with probiotic intervention (Figure 5). Normalized for relative 
abundance taxonomic tables were collapsed to various taxo-
nomic ranks, namely phylum, family, genus, and species. Each 
taxonomic rank table was evaluated per taxon for association 
with the probiotic intervention using a Mann–Whitney U test 
(P-values < 0.05 considered significant). Significant taxon 
shifts observed across all samples as well as after stratifying by 
normal and overweight weight status were retained for genera-
tion of a bar plot describing the number of significantly 
impacted taxa after probiotics intervention (Figure 6).
Among the taxa significantly impacted by the intervention 
period, we decided to look closer at the difference in this impact 
between normal and overweight individuals. For instance, at 
the family level, overweight subjects were significantly depleted 
of Bacteroidaceae while normal subjects experienced a signifi-
cant increase in Bacteroides after probiotics intervention (Figure 
7A). A closer inspection of the species Bacteroides ovatus, an 
anaerobic gram-negative bacteria from the phylum Bacteroidetes, 
revealed a similar significant discrepancy between normal and 
overweight subjects (Figure 7B), likely contributing to the dis-
tinction seen in the Bacteroidaceae family. The Lachnospira 
genus was also found to be significantly impacted by interven-
tion, but there was no significant relationship to weight status 
in this change (Figure 7C).
Phylogenetic diversity among normal and 
overweight children microbiomes
The heatmap (Figure 8) demonstrates the increase or decrease 
of all microbes specified at the phylum level in individuals after 
the probiotics intervention. Among all the phyla found, none 
showed a significant difference after intervention. The distinc-
tion between normal and overweight individuals is minimal, 
phylum-specific differences between the weight statuses were 
not found. So, we generated another heatmap describing taxa 
at the genus level after the probiotics intervention (Figure 9). 
Only genera showing a significant change (P < 0.05) across all 
individuals during intervention are displayed, hierarchically 
clustered according to their correlation with the intervention. 
Positively correlated genera with intervention are shown in 
blue, largely from the Bacteroidetes (Bacteroides, Alistipes, 
Odoribacter) and Firmicutes (Oscillospira, Lachnospira) phyla 
despite the lack of significance in intervention found in those 
phyla overall. Meanwhile, genera in the Proteobacteria 
(Acinetobacter, Pseudomonas, Proteus) phylum appeared to sig-
nificantly decrease with the probiotics intervention.
Discussion
Obesity has grown as an emerging public health problem 
worldwide affecting more than 24% children and adolescents.22 
Studies have demonstrated there are at least 18 co-morbidities 
that are attributed to overweight status and obesity including 
type 2 diabetes mellitus, cardiovascular diseases, Alzheimer’s 
disease, and cancer.23,24 Recent studies indicate that probiotics 
Table 2. Permutational Analysis of Variance (PERMANOVA) on RDA 
constraints in phase 1 (A). and phase 2 (B) populations. “Prop. Var. 
Explained” is a percentage of unconstrained RDA variance explained 
by each variable. 
A
VARiABLE R-SQUARED PROP. VAR. 
ExPLAiNED (%)
P-VALUE
Week 0.392 4.34 0.01**
Weight 0.246 3.05 0.01**
Age 0.130 3.79 0.02*
After Prob. 0.257 5.64 0.01**
Female 0.040 3.44 0.108
Overweight 0.003 2.21 0.841
B
VARiABLE R-SQUARED PROP. VAR. 
ExPLAiNED (%)
P-VALUE
Week 0.390 3.41 0.01**
Weight 0.266 4.11 0.01**
Age 0.068 2.66 0.118
After Prob. 0.039 1.25 0.089
Female 0.040 3.05 0.040*
Overweight 0.024 2.44 0.242
P-values < 0.05 were considered significant and are shown in boldface.
*P < 0.05, **P < 0.01.
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species play significant roles in sustaining the gut microbiota 
ecosystem in humans and help prevent obesity. Various studies 
investigated the association between obesity and the composi-
tion of the gut microbiota. This study was our first attempt to 
understand the impact of probiotics consumption on the gut 
microbiome diversity in normal and overweight children from 
Malaysia, a previously underrepresented group in microbiome 
literature.
Our results show that probiotic consumption (intervention) 
has led to different microbial alterations among normal-weight 
children compared to overweight children. Many studies have 
reported a lower alpha diversity in obese compared to normal-
weight humans, but we found probiotics intervention did not 
significantly impact alpha diversity in 1 weight status group over 
the other.25-27 Rather, our pilot study found distinctions between 
Figure 4. Principal coordinates analysis (PCoA) using weighted UniFrac distance displaying all individuals, stratified by weight status. Only samples 
immediately prior to and after the probiotic drink intervention are displayed, connected by an arrow indicating the direction of movement from before 
intervention to after intervention.
Figure 5. Changes in the relative abundance of taxa at the genus level before intervention and after intervention, per subject. Only the first 14 most 
abundant genera overall are named, others are summed up into an “Other” category.
Figure 6. A bar chart indicating the number of taxa at varying taxonomic 
levels found to be significantly impacted by the probiotics intervention, 
regardless of weight status or another confounding variable. Significance 
was evaluated by a Mann–Whitney U test per taxon, with P-values < 0.05 
considered significant.
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weight statuses were primarily concentrated in overall microbial 
composition, where the probiotic drink had differing impacts on 
the child’s specific gut microbes depending on weight status.
Beta diversity analyses revealed the intervention may have 
caused perturbations in all the participants’ microbiomes. 
PCoA analysis per individual suggests that the populations’ 
microbiomes varied throughout the study, but significant 
impacts of intervention were sustained in the phase 1 group 
drinking the probiotic earlier in the study according to both 
weighted UniFrac measures and RDA. Constrained RDA 
revealed a significant impact of weight status on a smaller pro-
portion of variance than described in weighted UniFrac and 
PCoA, but implies there are weight status distinctions among 
less influential taxa. The results are consistent with a study 
reported by Lin et al (2015) where a significantly distinct beta 
diversity was observed in obese individuals compared to that of 
normal weight.28 Conversely, there are studies reporting an 
unchanged beta diversity between similar groups, so there is 
Figure 7. A closer look at taxa significantly impacted by intervention phases. in these plots, purple indicates a positive impact, orange indicates a 
negative impact. The family Bacteroidaceae (A) showed a significant difference between normal weight and overweight children in terms of intervention 
impact on the taxon (Mann–Whitney U test, P = 0.031). Within the Bacteroidaceae family is the Bacteroides ovatus species (B), which showed a similar 
significant distinction between weight statuses (Mann–Whitney U test, P = 0.017). However, not all taxa significantly impacted by the intervention were 
necessarily distinct in their intervention impact between weight statuses, as shown by the Lachnospira genus (Mann–Whitney U test, P = 0.12).
Figure 8. Heatmap demonstrating the increase or decrease of microbes at the phylum level in individuals during the probiotics intervention phase. Blue 
indicates an increase in that phylum while red indicates a decrease in relative abundance.
Figure 9. Heatmap demonstrating the increase or decrease of microbes at the genus level in individuals during the probiotics intervention phase. Blue 
indicates an increase in that phylum while red indicates a decrease in relative abundance.
Joseph et al 9
more work to be done with larger studies in a variety of geo-
graphic populations.29,30
Considering the relatively small proportion of variance in 
gut bacterial composition explained in our constrained RDA, 
we could presume that the effects on alpha and beta diversities 
differ according to various confounding factors not included in 
our analysis such as diet, physical activity, and geographical 
location of the participants’ homes.31 We believe inconsisten-
cies in literature and our findings may be results of the complex 
relationships between environmental, genetic, diet or clinical 
factors.32,33 We also believe our population size and study 
design limited our exploration of overall bacterial composition, 
as the sample sizes were too small to overcome individual bias 
in many instances of analysis.
Analysis of the bacterial community at the species level found 
that the proportions of Bacteroides ovatus, an anaerobic, gram-
negative bacteria from the Bacteroides genus commonly found in 
the gut was markedly increased in normal-weight children but 
depleted in overweight children after the probiotics intervention. 
This is in agreement with other similar studies that reported an 
increase in bacterial species from the phylum Bacteroidetes in lean 
individuals. There was an increase in the bacterial species such as 
Bacteroides thetaiotaomicron and Bacteroides faecichinchillae from 
Bacteroides phylum and Blautia wexlerae, Clostridium bolteae, and 
Flavonifractor plautii species from the Firmicutes phylum among 
lean individuals. On the other hand, obese individuals had a 
larger composition on bacterial species belonging to the 
Firmicutes phylum such as Blautia hydrogenotorophica, Coprococcus 
catus, Eubacterium ventriosum, Ruminococcus bromii, and 
Ruminococcus obeum.3,34-37 These findings support the association 
of obesity with bacterial species from the Firmicutes and 
Bacteroidetes phyla. Future studies should focus on directly tar-
geting theses phyla to differentiate weight status.
Finally, at genus level comparisons, Lachnospira and 
Ruminococcus were found to increase among overweight par-
ticipants compared to normal weight participants. These find-
ings, however, contradict previous studies. Previous studies 
have demonstrated that Ruminococcaceae and Lachnospiraceae 
are associated with SCFAs production and these genera were 
found to be depleted in overweight individuals compared to 
lean individuals.38,39
Our findings imply microbial dysbiosis is not a discriminative 
feature to distinguish overweight and normal-weight individu-
als. Rather, our results imply microbial composition can be suc-
cessfully altered in either weight status with probiotics, but these 
alterations may be distinct between overweight and normal-
weight children at various taxonomic ranks. The major limita-
tions of our pilot study are the short intervention period and 
population size. A longer period of intervention could help us 
more precisely identify the effects of probiotics on the Malaysian 
child gut microbiome. Confounding factors such as physical 
activity and diet could also be better reported to identify their 
impact on probiotics and gut microbiota in both normal and 
overweight children.40
Overall, our probiotics intervention was found to have 
numerous impacts across the participants regardless of weight 
status or intervention period, implying that the microbiome 
can be altered with probiotics with a significant chance of suc-
cess. Yet, there is limited evidence supporting a distinct micro-
biome composition in overweight children as compared to 
normal-weight children following probiotics. This pilot study 
provides a framework for future research to study the effect of 
probiotics intervention on the gut microbiota profile.
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